AKT1 and gastric cancer: Furthermore, recent evidence revealed that miR-383-5p is upregulated in allicin-treated gastric cancer cells, leading to the suppression of ERBB4-related oncogenic signaling such as PI3K/Akt [29] (Figure 1 and Table 4).